- Home
- IMNN vs GELS Comparison
IMNN vs GELS Comparison
Compare IMNN & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- GELS
- Stock Information
- Founded
- IMNN 1982
- GELS 2018
- Country
- IMNN United States
- GELS Australia
- Employees
- IMNN N/A
- GELS N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- GELS
- Sector
- IMNN Health Care
- GELS
- Exchange
- IMNN Nasdaq
- GELS NYSE
- Market Cap
- IMNN 13.6M
- GELS 12.6M
- IPO Year
- IMNN 1985
- GELS 2024
- Fundamental
- Price
- IMNN $0.96
- GELS $0.90
- Analyst Decision
- IMNN Strong Buy
- GELS
- Analyst Count
- IMNN 2
- GELS 0
- Target Price
- IMNN $21.50
- GELS N/A
- AVG Volume (30 Days)
- IMNN 131.6K
- GELS 29.4K
- Earning Date
- IMNN 05-12-2025
- GELS 02-15-2025
- Dividend Yield
- IMNN N/A
- GELS N/A
- EPS Growth
- IMNN N/A
- GELS N/A
- EPS
- IMNN N/A
- GELS N/A
- Revenue
- IMNN N/A
- GELS $95,618.00
- Revenue This Year
- IMNN N/A
- GELS N/A
- Revenue Next Year
- IMNN N/A
- GELS N/A
- P/E Ratio
- IMNN N/A
- GELS N/A
- Revenue Growth
- IMNN N/A
- GELS N/A
- 52 Week Low
- IMNN $0.64
- GELS $0.82
- 52 Week High
- IMNN $3.65
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- IMNN 48.88
- GELS N/A
- Support Level
- IMNN $1.01
- GELS N/A
- Resistance Level
- IMNN $1.10
- GELS N/A
- Average True Range (ATR)
- IMNN 0.08
- GELS 0.00
- MACD
- IMNN -0.00
- GELS 0.00
- Stochastic Oscillator
- IMNN 33.36
- GELS 0.00
Stock Price Comparison Chart: IMNN vs GELS
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.